EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countries.


Journal

Annals of the rheumatic diseases
ISSN: 1468-2060
Titre abrégé: Ann Rheum Dis
Pays: England
ID NLM: 0372355

Informations de publication

Date de publication:
11 2020
Historique:
received: 06 04 2020
revised: 10 06 2020
accepted: 28 07 2020
pubmed: 3 9 2020
medline: 15 12 2020
entrez: 3 9 2020
Statut: ppublish

Résumé

As part of European League against Rheumatism (EULAR)/European Musculoskeletal Conditions Surveillance and Information Network, 20 user-focused standards of care (SoCs) for rheumatoid arthritis (RA) addressing 16 domains of care were developed. This study aimed to explore gaps in implementation of these SoCs across Europe. Two cross-sectional surveys on the importance, level of and barriers (patients only) to implementation of each SoC (0-10, 10 highest) were designed to be conducted among patients and rheumatologists in 50 European countries. Care gaps were calculated as the difference between the actual and maximum possible score for implementation (ie, 10) multiplied by the care importance score, resulting in care gaps (0-100, maximal gap). Factors associated with the problematic care gaps (ie, gap≥30 and importance≥6 and implementation<6) and strong barriers (≥6) were further analysed in multilevel logistic regression models. Overall, 26 and 31 countries provided data from 1873 patients and 1131 rheumatologists, respectively. 19 out of 20 SoCs were problematic from the perspectives of more than 20% of patients, while this was true for only 10 SoCs for rheumatologists. Rheumatologists in countries with lower gross domestic product and non-European Union countries were more likely to report problematic gaps in 15 of 20 SoCs, while virtually no differences were observed among patients. Lack of relevance of some SoCs (71%) and limited time of professionals (66%) were the most frequent implementation barriers identified by patients. Many problematic gaps were reported across several essential aspects of RA care. More efforts need to be devoted to implementation of EULAR SoCs.

Identifiants

pubmed: 32873554
pii: annrheumdis-2020-217520
doi: 10.1136/annrheumdis-2020-217520
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1423-1431

Investigateurs

Miroslav Mayer (M)
Inessa Samko (I)
Leszek Roszkowski (L)
Zumrad Hamroeva (Z)
Antonella Celano (A)
Šárka Forejtová (Š)
Tuuluki Sokka (T)
Lars Hagen (L)
Johan Joly (J)
Ivica Jeremic (I)
Bernadette Rojkovich (B)
Laurence Carton (L)
Sonia Tropé (S)
Randi Petersen (R)
Kim Hørslev-Petersen (K)
Ilker Yagcı (I)
Ermir Tafaj (E)
Edi Rembeci (E)

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Rachelle Meisters (R)

Health Services Research, Maastricht University, Maastricht, The Netherlands r.meisters@maastrichtuniversity.nl.
Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.

Polina Putrik (P)

Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.
Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands.

Sofia Ramiro (S)

Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
Rheumatology, Zuyderland Medical Center, Heerlen, The Netherlands.

Monika Hifinger (M)

Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.
Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands.

Andras P Keszei (AP)

Center for Translational & Clinical Research Aachen (CTC-A), Uniklinik RWTH Aachen University, Aachen, Germany.

Yvonne van Eijk-Hustings (Y)

Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands.

Anthony D Woolf (AD)

Bone and Joint Research Group, Royal Cornwall Hospital, Truro, UK.

Josef S Smolen (JS)

Division of Rheumatology, Department of Medicine, Medical University of Vienna, Vienna, Austria.

Tanja A Stamm (TA)

Section for Outcomes Research, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria.

Michaela Stoffer-Marx (M)

Section for Outcomes Research, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.

Till Uhlig (T)

Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.

Rikke Helene Moe (RH)

Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.

Maarten de Wit (M)

EULAR Patient Research Partner, Zaltbommel, The Netherlands.

Argjend Tafaj (A)

Rheumatology Clinic, Medical University of Tirana, Tirana, Albania.

Vahan Mukuchyan (V)

Department of Rheumatology, Erebouni Medical Center, Yerevan, Armenia.

Paul Studenic (P)

Department of Internal Medicine 3, Division of Rheumatology, Medical University Vienna, Vienna, Austria.

Patrick Verschueren (P)

Rheumatology, University Hospitals Leuven, Leuven, Belgium.

Russka Shumnalieva (R)

Clinic of Rheumatology, Department of Internal Medicine, Medical University-Sofia, Sofia, Bulgaria.

Paraskevi Charalambous (P)

Cyprus Society for Rheumatology, Nicosia, Cyprus.

Jiří Vencovský (J)

Institute of Rheumatology, Department of Rheumatology, Charles University, Prague, Czech Republic.

Melpomeni Varvouni (M)

Danish Hospital for Rheumatic Diseases, Sonderborg, Denmark.

Mart Kull (M)

Department of Internal Medicine, Tartu University, Tartu, Estonia.

Kari Puolakka (K)

Department of Medicine, Lappeenranta Central Hospital, Lappeenranta, Finland.

Laure Gossec (L)

INSERM, Sorbonne Universite, Paris, Île-de-France, France.
Rheumatology, Hopital Universitaire Pitie Salpetriere, AP-HP, Paris, Île-de-France, France.

Nino Gobejishvili (N)

Georgian Young Rheumatologists Union (SARG), Tbilisi, Georgia.

Jacqueline Detert (J)

Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Prodromos Sidiropoulos (P)

Rheumatology, Allergy, Clinical Immunology, University of Crete, Thessaloniki, Greece.

Márta Péntek (M)

Department of Health Economics, Corvinus University of Budapest, Budapest, Hungary.
Rheumatology, Flór Ferenc County Hospital, Kistarcsa, Hungary.

David Kane (D)

Rheumatology, Trinity College Dublin, Dublin, Ireland.

Carlo Alberto Scirè (CA)

Epidemiology Unit, Italian Society for Rheumatology (SIR), Milan, Italy.

Uri Arad (U)

Department of Rheumatology, Tel-Aviv Medical Center, Tel-Aviv, Israel.

Daina Andersone (D)

Rheumatology, Pauls Stradina Clinical University Hospital, Riga, Latvia.

Mart van de Laar (M)

Arthritis Center @ Medisch Spectrum Twente, Enschede, The Netherlands.
PHT, University of Twente, Enschede, The Netherlands.

Annette van der Helm-van Mil (A)

Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.

Piotr Głuszko (P)

National Institute of Geriatrics, Rheumatology, and Rehabilitation, Warsaw, Poland.

Luís Cunha-Miranda (L)

Rheumatology, Portuguese Institute of Rheumatology, Lisbon, Portugal.

Florian Berghea (F)

Department of Internal Medicine and Rheumatology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.

Nemanja S Damjanov (NS)

Rheumatology, University of Belgrade School of Medicine, Belgrade, Serbia.

Matija Tomšič (M)

Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia.

Loreto Carmona (L)

Instituto de Salud Musculoesquelética, Madrid, Spain.

Carl Turesson (C)

Rheumatology, Department of Clinical Sciences, Lund University, Malmö, Sweden.

Adrian Ciurea (A)

Rheumatology, University Hospital Zurich, Zurich, Switzerland.

Surayo Shukurova (S)

Internal Medicine, Medical Science Academy, Dushanbe, Tajikistan.

Nevsun Inanc (N)

Division of Rheumatology, School of Medicine, Marmara University, Istanbul, Turkey.

Suzanne Mm Verstappen (SM)

Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.

Annelies Boonen (A)

Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.
Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH